medicina Article Peripheral Artery Disease and Abdominal Aortic Aneurysm: The Forgotten Diseases in COVID-19 Pandemic. Results from an Observational Study on Real-World Management Francesco Natale 1,*, Raffaele Capasso 2 , Alfonso Casalino 3, Clotilde Crescenzi 3, Paolo Sangiuolo 3, Paolo Golino 1,2, Francesco S. Loffredo 1,2,4 and Giovanni Cimmino 2,5 1 Vanvitelli Cardiology and Intensive Care Unit, Monaldi Hospital, 80131 Naples, Italy;
[email protected] (P.G.);
[email protected] (F.S.L.) 2 Department of Translational Medical Sciences, Section of Cardiology, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy;
[email protected] (R.C.);
[email protected] (G.C.) 3 Vascular Surgery Unit, Monaldi Hospital, 80131 Naples, Italy;
[email protected] (A.C.);
[email protected] (C.C.);
[email protected] (P.S.) 4 Molecular Cardiology, International Centre for Genetic Engineering and Biotechnology, 34149 Trieste, Italy 5 Cardiology Unit, Policlinico Vanvitelli, 80138 Naples, Italy * Correspondence:
[email protected]; Tel.:+39-0817064239 Abstract: Background and Objectives: It is well established that patients with peripheral artery disease Citation: Natale, F.; Capasso, R.; (PAD) as well abdominal aortic aneurysm (AAA) have an increased cardiovascular (CV) mortality. Casalino, A.; Crescenzi, C.; Despite this higher risk, PAD and AAA patients are often suboptimality treated. This study assessed Sangiuolo, P.; Golino, P.; the CV profile of PAD and AAA patients, quantifying the survival benefits of target-based risk-factors Loffredo, F.S.; Cimmino, G. modification even in light of the COVID-19 pandemic. Materials and Methods: PAD and AAA patients Peripheral Artery Disease and admitted for any reason to the Vascular Unit from January 2019 to February 2020 were retrospectively Abdominal Aortic Aneurysm: The analyzed.